[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69616719D1 - Verfahren zur herstellung von taxol und seiner derivate - Google Patents

Verfahren zur herstellung von taxol und seiner derivate

Info

Publication number
DE69616719D1
DE69616719D1 DE69616719T DE69616719T DE69616719D1 DE 69616719 D1 DE69616719 D1 DE 69616719D1 DE 69616719 T DE69616719 T DE 69616719T DE 69616719 T DE69616719 T DE 69616719T DE 69616719 D1 DE69616719 D1 DE 69616719D1
Authority
DE
Germany
Prior art keywords
formula
compound
aryl
heteroaryl
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69616719T
Other languages
English (en)
Other versions
DE69616719T2 (de
Inventor
Cesare Gennari
Nicola Mongelli
Ermes Vanotti
Anna Vulpetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Publication of DE69616719D1 publication Critical patent/DE69616719D1/de
Application granted granted Critical
Publication of DE69616719T2 publication Critical patent/DE69616719T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69616719T 1995-06-20 1996-06-04 Verfahren zur herstellung von taxol und seiner derivate Expired - Lifetime DE69616719T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9512471.5A GB9512471D0 (en) 1995-06-20 1995-06-20 Method for the preparation of taxol and its derivatives
PCT/EP1996/002409 WO1997000870A1 (en) 1995-06-20 1996-06-04 Method for the preparation of taxol and its derivatives

Publications (2)

Publication Number Publication Date
DE69616719D1 true DE69616719D1 (de) 2001-12-13
DE69616719T2 DE69616719T2 (de) 2002-08-01

Family

ID=10776319

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69616719T Expired - Lifetime DE69616719T2 (de) 1995-06-20 1996-06-04 Verfahren zur herstellung von taxol und seiner derivate

Country Status (17)

Country Link
US (1) US5767282A (de)
EP (2) EP0776322B1 (de)
JP (1) JP3889047B2 (de)
KR (1) KR970705552A (de)
CN (1) CN1179955C (de)
AT (1) ATE208381T1 (de)
AU (1) AU712898B2 (de)
CA (1) CA2197467C (de)
DE (1) DE69616719T2 (de)
ES (1) ES2168489T3 (de)
GB (1) GB9512471D0 (de)
HU (1) HUP9702399A3 (de)
IL (1) IL120165A (de)
MX (1) MX9701274A (de)
NO (1) NO970766D0 (de)
WO (1) WO1997000870A1 (de)
ZA (1) ZA964951B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150537A (en) * 1997-12-12 2000-11-21 Emory University Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
WO2000047434A1 (en) 1999-02-10 2000-08-17 Erik Zapletal Balanced suspension system
IT1308636B1 (it) * 1999-03-02 2002-01-09 Indena Spa Procedimento per la preparazione di tassani da 10-desacetilbaccatinaiii.
AU757591B2 (en) 1999-04-12 2003-02-27 Kinetic Pty Limited Active ride control for a vehicle suspension system
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6143900A (en) * 1999-10-26 2000-11-07 Dong Kook Pharmaceutical Co., Ltd. Stereoselective synthesis of oxazoline derivative
PL194032B1 (pl) * 2002-12-19 2007-04-30 Agropharm Sa Sposób wytwarzania półproduktów użytecznych w syntezie paklitakselu
CN101020672B (zh) * 2006-12-28 2010-08-25 上海百灵医药科技有限公司 多烯紫杉醇的合成方法
CN101007795B (zh) * 2007-01-26 2010-08-18 浙江大学 紫杉醇及多烯紫杉醇的合成方法
CN115260130A (zh) * 2022-07-07 2022-11-01 上海卓鼎生物技术有限公司 一种10-脱乙酰基紫杉醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2687151B1 (fr) * 1992-02-07 1994-03-25 Rhone Poulenc Rorer Sa Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2696458B1 (fr) * 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.

Also Published As

Publication number Publication date
NO970766L (no) 1997-02-19
CN1179955C (zh) 2004-12-15
CA2197467C (en) 2008-02-12
ATE208381T1 (de) 2001-11-15
EP1116718A3 (de) 2001-08-29
CA2197467A1 (en) 1997-01-09
HUP9702399A3 (en) 1999-12-28
EP1116718A2 (de) 2001-07-18
HUP9702399A2 (hu) 1998-07-28
AU712898B2 (en) 1999-11-18
IL120165A (en) 2002-02-10
CN1158126A (zh) 1997-08-27
NO970766D0 (no) 1997-02-19
ES2168489T3 (es) 2002-06-16
US5767282A (en) 1998-06-16
EP0776322A1 (de) 1997-06-04
AU6221596A (en) 1997-01-22
EP0776322B1 (de) 2001-11-07
MX9701274A (es) 1997-05-31
WO1997000870A1 (en) 1997-01-09
JPH10505360A (ja) 1998-05-26
ZA964951B (en) 1997-01-23
DE69616719T2 (de) 2002-08-01
JP3889047B2 (ja) 2007-03-07
GB9512471D0 (en) 1995-08-23
KR970705552A (ko) 1997-10-09
IL120165A0 (en) 1997-06-10

Similar Documents

Publication Publication Date Title
ATE174589T1 (de) Verfahren zur herstellung von piperidinderivaten
DE69719781D1 (de) Zwischenprodukte zur Herstellung von Duocarmycin SA und dessen Derivaten sowie ein Verfahren zur Herstellung der Zwischenprodukte
ATE248595T1 (de) Herstellungsverfahren fuer piperidinderivate
MY149146A (en) Processes and intermediates useful in the preparation of pharmaceutical compounds such as fulvestrant
ATE202087T1 (de) Verfahren zur herstellung von 4-substituierten azetidinon-derivaten
DE69515882D1 (de) Verfahren zur herstellung von antimikrobiellen verbindungen
DE69616719D1 (de) Verfahren zur herstellung von taxol und seiner derivate
ATE519747T1 (de) Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten
DE69527787D1 (de) Verfahren und zwischenprodukte zur herstellung von piperazinderivaten
ATE540934T1 (de) Verfahren zur herstellung substituierter anilinverbindungen
DE69912984D1 (de) Derivate des 6-(4-phenylbutoxy)hexylamins und verfahren zur herstellung von salmeterol
DE60116201D1 (de) Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen
DE69937988D1 (de) Verfahren zur herstellung von 3-cephemderivaten
DE69800922D1 (de) Verfahren zur Herstellung von 2-Cyanobiphenyl Verbindungen
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
DE69202564D1 (de) Verfahren zur Herstellung von 1,3-Dioxan-4,6-Dionderivaten.
DE60003711D1 (de) Verfahren zur herstellung von peptidzwischenprodukten
DE69333240D1 (de) Verfahren zur herstellung von enantiomerreinen fluorierten epoxychromanen
EP1104424A4 (de) Verfahren zur synthese von carbapenem-zwischenprodukten und hergestellte verbindungen
ATE449780T1 (de) Derivate von ä2-(8,9-dioxo-2,6- diazabicycloä5.2.0ünon-1(7)-en-2- yl)alkylüphosphonsäure und verfahren zu deren herstellung
DE3772703D1 (de) Verfahren zur herstellung von penemen.
NZ331599A (en) 1(2h)-quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesising substances having antibiotic properties
DE69815906D1 (de) Verfahren zur Herstellung von Chloroacetylaminothiazoleaceticsäure Derivate
ATE555089T1 (de) Verfahren zur herstellung von -ketoacetalen
ATE210115T1 (de) Verfahren zur herstellung von (1'r,3s,4r)4- acylthioazetidinonen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 776322

Country of ref document: EP

Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN, DE